Canaccord Genuity on Life Sciences: Generic Adderall XR Approval Offers Several Cross-stock Implications

June 25, 2012 9:56 AM EDT Send to a Friend
Canaccord Genuity on Life Sciences/Specialty Pharma: Generic Adderall XR Approval Offers Several Cross-stock Implications

Analyst, Randall Stanicky, said, "The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login